The U.S. Food and Drug Administration approved Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older who currently have stage 2 type 1 diabetes.
source https://www.pharmatutor.org/pharma-news/2022/fda-approves-first-drug-that-can-delay-onset-of-type-1-diabetes
No comments:
Post a Comment